来自韩国全国实况数据库的注意力缺陷/多动症患者治疗模式的最新更新
Yoon Cho1, Ah-Young Kim2, Sukhyang Lee1,2,3
1Department of Biohealth Regulatory Science, Graduate School of Ajou University.
International clinical psychopharmacology
|March 13, 2024
概括
韩国注意力缺陷/多动症 (ADHD) 治疗模式显示儿科和成人患者之间存在显著差异. 分析揭示了活跃与短暂的多动症患者的不同特征和药物选择.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 在韩国,注意力缺陷/多动症 (ADHD) 患病率正在上升.
- 了解ADHD患者的特征和治疗模式对于有效的医疗管理至关重要.
研究的目的:
- 分析韩国的ADHD患者特征和药物 (Rx) 治疗模式.
- 为了比较有和没有ADHD药物的患者.
- 确定在接受治疗的儿科/成人和活跃/过渡性ADHD患者之间的差异.
主要方法:
- 一项采用2020-2021年全国索赔数据集进行的横截面研究.
- 分析了132,017名服用药物的多动症患者与20,312名没有服用药物的多动症患者.
- 人口,临床和治疗模式差异的比较.
主要成果:
- 在儿科/成人和活跃/过渡性ADHD患者之间的特征和治疗模式中发现了显著的差异.
- 在儿科患者中,特定年龄的性别比率有所不同;精神病相关疾病有所不同.
- 甲基胺 (89.7%) 是主要的药物,其中85%经历了配方变化. 儿科患者更喜欢延长释放甲基化物,而成年人更喜欢口服配方.
结论:
- 这项研究为韩国最近的多动症治疗模式提供了重要的流行病学见解.
- 研究结果突出了儿童与成人和活跃与短暂的多动症患者的不同情况.
- 这些证据对未来的医疗保健政策和识别积极参与ADHD治疗的患者有价值.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.7K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.3K
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
59
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
59
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
55
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
55